Heron Therapeutics

This study tested an experimental pain medication called HTX-011, given as a nerve block before breast augmentation surgery. Researchers wanted to see if it reduced pain better than standard options and lowered the need for opioid painkillers after the operation. The study involv…

This large, completed Phase 3 trial tested if a new drug called APF530 works as well or better than the standard drug Aloxi (palonosetron) to prevent nausea and vomiting in cancer patients receiving chemotherapy. Over 1,400 patients participated, receiving either the new drug or …

This study tested two new long-acting numbing medicines, HTX-011 and HTX-002, to see if they could better control pain after a tummy tuck surgery. It involved 277 adults to compare the pain relief and safety of these new formulations against each other. The main goal was to measu…

This study tested an experimental pain medication called HTX-011. It was injected directly into the surgical site during knee replacement surgery to see if it could better control pain in the first few days after the operation. Researchers compared it to a standard pain treatment…

This study tested whether a new medicine called HTX-011 could better control pain and reduce the need for opioid painkillers after hernia surgery. Researchers compared HTX-011 against both a placebo (saltwater injection) and a standard pain medicine in 418 patients. The medicine …

This study tested three experimental gels designed to relieve pain after bunion surgery. The gels were applied directly to the surgical site and contained different combinations of pain-relieving medications. Researchers compared them to see which worked best at reducing pain in …

This study tested a planned, non-opioid approach to managing pain after total knee replacement surgery. All 116 participants received an experimental long-acting numbing medicine (HTX-011) as part of a scheduled multi-drug plan. The main goal was to see how well this approach con…

This study tested whether a new non-opioid pain treatment (HTX-011) could help patients use fewer opioid painkillers after hernia repair surgery. It involved 63 adults having a specific type of groin hernia operation. The main goal was to see how many patients could manage their …

This study tested a new pain medicine called HTX-011, which is applied directly to the surgical site during bunion surgery. The goal was to see if it could reduce pain better than a placebo (saltwater injection) or a standard local anesthetic, and if it could help patients use fe…

This study tested an experimental pain medication called HTX-011. It was injected directly into the surgical site during bunion surgery to see if it could reduce pain and the need for opioid painkillers afterward. The trial involved 78 people and measured their pain levels and me…

This study tested several new long-acting pain relief injections given during hernia surgery. The goal was to see if these new formulations could safely reduce pain for patients in the first 24 hours after their operation. Researchers compared different drug combinations to find …

This study tested whether a new injection called APF530 works better than the standard drug ondansetron at preventing nausea and vomiting in cancer patients receiving strong chemotherapy. The trial involved 942 adults who were starting their first round of chemotherapy known to c…

This study tested whether APF530, an experimental medication, affects heart rhythm in healthy people. Researchers measured heart activity in 56 volunteers to check for any safety concerns. The study compared APF530 against placebo and other drugs to understand its effects on the …